Market Report, "Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2013", published

From: Fast Market Research, Inc.
Published: Tue Feb 04 2014

Global Market Direct's pharmaceuticals report, "Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2013" provides data on the Aslan Pharmaceuticals Pte. Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Aslan Pharmaceuticals Pte. Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Aslan Pharmaceuticals Pte. Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at


* Aslan Pharmaceuticals Pte. Ltd. - Brief Aslan Pharmaceuticals Pte. Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Aslan Pharmaceuticals Pte. Ltd. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Aslan Pharmaceuticals Pte. Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Aslan Pharmaceuticals Pte. Ltd.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Evaluate Aslan Pharmaceuticals Pte. Ltd.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Aslan Pharmaceuticals Pte. Ltd. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Aslan Pharmaceuticals Pte. Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Aslan Pharmaceuticals Pte. Ltd..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Aslan Pharmaceuticals Pte. Ltd. and identify potential opportunities in those areas.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2012
- MerLion Pharmaceuticals Pte Ltd - Product Pipeline Review - 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Glenmark Pharmaceuticals Ltd. - Product Pipeline Review - 2013
- Spectrum Pharmaceuticals, Inc. - Product Pipeline Review - 2013

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »